A miniature atom-based magnetic sensor developed by the National Institute of Standards and Technology (NIST) has passed an important research...
Scientists have discovered a biological marker that may help to identify which depressed patients will respond to an experimental, rapid-acting antidepressant like ketamine. The brain signal, detectable by noninvasive imaging, also holds clues to the agent's underlying mechanism, which are vital for drug development, say NIH researchers.
Researchers discover four spectral features in the brain signals of schizophrenia patients that changed with age compared to healthy control subjects, suggesting that schizophrenia affects the way in which brain activity evolves with age.
Using MEG brain scans, which are a speedier alternative to fMRI, researchers are discovering new insights into how brain regions work together.
Two new NIH grants will allow researchers to combine neuroimaging techniques to better explore autism.
A new neuroimaging study identifies areas of the brain responsible for language processing.